Literature DB >> 9654595

Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity.

A Ladányi1, J O Nagy, A Jeney, J Tímár.   

Abstract

The effect of a panel of cytokines on the proliferation and type IV collagenase production was studied in four melanoma cell lines of different origin, tumorigenicity and metastatic capacity. TGF-b, TNF-a and to a lesser extent, IL-1a exhibited antiproliferative effect on the cell lines, with some lines showing varying degree of resistance. The sensitivity did not correlate directly with the origin or the biological behavior of the tumor lines, suggesting that cytokine resistance of advanced stage melanoma cells may be relative. IL-2, IL-10 and IL-12 displayed little or no effect on proliferation. The effect of cytokines on metalloproteinase production showed a cell line dependent pattern. Interestingly, those cytokines that exhibited the most pronounced antiproliferative activity, also proved most effective in stimulating collagenase secretion, often simultaneously, in the same line. The results indicate that pleiotropic cytokines can have positive and negative effects simultaneously on various steps of tumor progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654595     DOI: 10.1007/bf02904703

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  46 in total

1.  Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.

Authors:  M R Bani; J Rak; D Adachi; R Wiltshire; J M Trent; R S Kerbel; Y Ben-David
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

2.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; S B Gruber; R J Muschel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

3.  Loss of transforming growth factor beta 1 regulatory activity in human non Hodgkin lymphomas.

Authors:  L Kopper; A Ladanyi; R Mihalik; P Nagy
Journal:  Anticancer Res       Date:  1994 Jan-Feb       Impact factor: 2.480

4.  Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

Authors:  P Huhtala; A Tuuttila; L T Chow; J Lohi; J Keski-Oja; K Tryggvason
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

5.  Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes.

Authors:  S Mattei; M P Colombo; C Melani; A Silvani; G Parmiani; M Herlyn
Journal:  Int J Cancer       Date:  1994-03-15       Impact factor: 7.396

6.  Human melanoma cells express a functional interleukin-2 receptor.

Authors:  S Plaisance; E Rubinstein; A Alileche; D S Han; Y Sahraoui; M C Mingari; R Bellomo; D Rimoldi; M P Colombo; C Jasmin
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

7.  Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma.

Authors:  Q Chen; V Daniel; D W Maher; P Hersey
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

8.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

9.  Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.

Authors:  M A Lauricella-Lefebvre; V Castronovo; H Sato; M Seiki; D L French; M P Merville
Journal:  Invasion Metastasis       Date:  1993

10.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Authors:  S A Rosenberg; J J Mulé; P J Spiess; C M Reichert; S L Schwarz
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  2 in total

1.  Expression of a decorin-like moleculein human melanoma.

Authors:  A Ladányi; M Gallai; S Paku; J O Nagy; J Dudás; J Tímár; I Kovalszky
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

Authors:  M D Boyano; M D Garcia-Vázquez; T López-Michelena; J Gardeazabal; J Bilbao; M L Cañavate; A G Galdeano; R Izu; L Díaz-Ramón; J A Raton; J L Díaz-Pérez
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.